麦肯锡给医药行业的报告-全英文ppt49)-医药保健(编辑修改稿)内容摘要:
ic。 third, patients are usually familiar with me and they will feel awkword.” —— Zhangyongxin town level clinic interview Yantai ~ 1 0~5~0~ 6 0~ 4 0~ 2 0~ 3 0~ 5 581997 1999 2020 Retail Pharmacy Hospital Clinic Jining ESTIMATE IN ADDITION, GYNO DAKTARIN NEEDS TO GROW THE MARKET SHARE ESPECIALLY THOSE OF COUNTY AND TOWN Source: Distributor interviews。 hospital pharmacy interviews。 retail pharmacy interviews。 McKinsey analysis Sales by strata Mn RMB, % Gyno Daktarin Xiaomishuan(消糜栓 ) Mycostatin(制霉菌素 ) Shuangzuotaishuan(双唑泰栓 ) Jie’eryin(洁尔阴 ) Vaginal infection drugs YANTAI amp。 JINING City County Town Village 26 50 20 42 47 12 24 43 32 41 46 13 3 59 38 9 43 27 4 0 0 0 0 22 Nail Fungal Infection Category Review FOR TINEA UNQUIUM DRUGS, DEMAND LATENCY IS EVEN HIGHER Percent Extremely latent demand with increasing awareness 90% of patients do not seek treatment Awareness and treatment rate is increasing slightly due to petitor39。 s heavy advertising Only around 10 % of those seeking treatment purchase drugs Only 1% would follow prescription Total incidence* Do not seek treatment Seek treatment Not aware 100~5~0~5~ 1 0~ 7 0~ 2 0 * The incidence rate is around 5% in Shandong Source: Physician and pharmacy interviews。 McKinsey analysis Only 1% actually buy drugs Low treatment rate is mainly due to affordability issue of the patients Sporanox’s potential market as a Tinea Unquium drug is small, and is unlikely to be a broadmarket hit Go to large hospital Go to clinic Go to pharmacy directly HOSPITAL CHANNEL IS STILL DOMINATING TINEA UNQUIUM DRUG MARKET WHILE PHARMACY CHANNEL IS PICKING UP Anecdotes Quantitative examples SubTA sales by channel Percent Source: Hospital pharmacy interviews。 Retail pharmacy interviews。 McKinsey analysis ~0~0 ~130~ 5 0~ 1 0~ 5 0~ 7 0~ 9 01997 1999 2020 Retail Pharmacy Hospital Clinic “ We gradually carry some Tinea Unquium drugs in these years. Because more and more patients, although still quite small in amount, e here to ask for Liangjia after seeing its advertisement. I think most patients still go to hospital for treatment.” —— Jining Kangfu pharmacy “ I seldom see Tinea Unquium patients. And also, because the drugs are very expensive, I didn’t carry them. If there is really someone e to my clinic, I will suggest them to pharmacy.” —— Yantai clinic interview Yantai ~5~5~0~ 2 0~ 1 5~ 1 0~ 7 5~ 8 0~ 9 01997 1999 2020 Retail Pharmacy Hospital Clinic Jining 25444 * Others including around five drugs, such as Huihuangmeisu( 灰黄霉素) , Lisulao( 里素劳) ,Lianghuija( 亮灰甲) etc. Source: Distributor interviews。 physician interviews。 patient interviews。 McKinsey analysis THERE ARE ONLY A FEW COMPETITORS AT CITY AND COUNTY LEVEL FOR SPORANOX。 LIANGJIA IS DOING BETTER THAN SPORANOX AT RETAIL PHARMACIES DUE TO HEAVY ADVERTISING 46241614Percent Others* Total = RMB million County Town City Sporanox Lanmeishu (兰美抒 ) Liangjia (亮甲 ) Village 0 Source: Distributor interviews。 physician interviews。 patient interviews。 McKinsey analysis THERE ARE ONLY A FEW COMPETITORS AT CITY AND COUNTY LEVEL FOR SPORANOX。 LIANGJIA IS DOING BETTER THAN SPORANOX AT RETAIL PHARMACIES DUE TO HEAVY ADVERTISING City Total Retail pharmacy Hospital 33402573210398203111514%25%29%26%Clinic County Share of leading drugs within Tinea Unquium – Yantai amp。 Jining Mn RMB, % 575461857427101417005%12%25%22%Total Retail pharmacy Hospital Clinic 100%= Sporanox Lanmeishu* (兰美抒 ) Liangjia (亮甲 ) Others Liangjia has relatively high market share in retail pharmacies At city level, Lanmeishu has 31% of hospital channel, better than Sporanox Hospital at county level and above should be the main focus PRICE IS A HUGE ISSUE FOR SPORANOX Sporanox is too expensive for most farmers whose annual ine is only around RMB 2,000 Even at county level, cost of using sporanox for effective treatment is higher than total drug expense per year for an average person 15 20~ 4 2 0~ 2 0 0~ 8 0~ 5 0 0County level price threashold City level price threashold County level annual drug expense per person Average insurance allowance per year Cost of sporanox as a derma drug Source: Interviews。 McKinsey analysis Cost of sporanox as a STD drug RMB FOR SPORANOX, XJP SHOULD CONTINUE TO FOCUS ON HOSPITALS … Retail pharmacy Hospital Clinic Source: Distributor interviews。 hospital pharmacy interviews。 retail pharmacy interviews。 McKinsey analysis Sales by channel Mn RMB, % Sporanox Lanmeishu* (兰美抒 ) Liangjia (亮甲 ) Tinea Unquium 65 33 69 30 1 84 15 0 12 87 2 2 YANTAI amp。 JINING … AND AT CITY AND RICH COUNTIES County Town Village Source: Distributor interviews。 hospital pharmacy interviews。 retail pharmacy interviews。 McKinsey analysis Sales by strata Mn RMB, % Sporanox Lanmeishu*(兰美抒 ) Liangjia(亮甲 ) City Tinea Unquium drugs 44 54 48 50 2 53 47 1 67 29 2 4 0 1 1 0 YANTAI amp。 JINING Vertigo Drug Category Review THERE IS UNTAPPED DEMAND IN TWO OF THE THREE PRODUCTRELATED TAs GI disfunction patient flow in broad market percent Sou。麦肯锡给医药行业的报告-全英文ppt49)-医药保健(编辑修改稿)
相关推荐
對全球品牌來說 → 如何取得及鞏固有利可圖的市場佔有率。 汽車業除了設計能力、品牌行銷及配銷等技能外,關鍵零組件也是公司維持競爭力的原因。 業者必須擬定一套策略,既可追求國內市場佔有率,又能控制成本。 打造在中國的銷售及配銷網路,以及在全球各地的產品及品牌開發工作。 製造外包給中國業者應該是西方汽車廠現在願意採取的蛙跳策略。 2020/9/18 18 重塑中國的大鋼鐵產業
机构投资 550亿美元的认购。 以 1999年为时间点, 99年以前的业务归母公司,属于中国人寿集团。 99年以后的业务以注资的形式注入上市公司,形成上市公司的资产。 2020/9/18 10 成功上市:新的里程碑 第一家在纽约和香港两地同时上市的内地保险公司。 第一家在海外上市的内地寿险公司。 今年在全球证券市场首次公开发行最大规模。 中国人寿的偿付能力是保监会规定的最低偿付能力的
环境中的竞争能力和竞争优势的合力,是其现有业务资源优势与运行机制(包括信息设施)的有机融合。 IT核心能力 就是以企业发展战略和经营理念为核心,优化企业的信息组织体系和职能架构,形成医药企业高效运行的管理系统和交流通畅的信息系统,助力于提高医药药品开发、创新和营销、生产产品的能力,提升医药的信息化建设水平和全员的知识、技术和工作能力,从而为培育和打造医药的核心竞争能力提供全面而有力的保障。
心竞争力不足 , 可能会 成为阻碍中国经济长期可持续发展的重大隐患 在国有企业仍占据经济主导地位的今天 , 缺乏 自有核心技术的产业竞争实质上造成了国有资 产的巨大损失 , 也构成了国家经济安全的重大 隐患 政府扶持本国产业的必要性 专利的获得手段有两种:自己研发;通过资本 获得。 以往中国拿市场换技术的做法是失败的 为了本国产业的长期发展 , 在关键时刻国家扶 持是必要的 , 如韩国的三星 、
支出。 “ 抚育恩情”综合保障计划 在为孩子提供教育经费的同时,还为孩子的婚嫁、养老等起到保障作用,真正让孩子在一生中得到父母无尽的爱。 14 热衷短期交费的家庭 “ 抚育恩情”综合保障计划 推出的 3年期短期交费方式,迎合了市场的需求,顺应了怕麻烦、对后期交费有担忧客户的要求。 15 高收入家庭 月收入在 1万元以上的家庭,此类人群除注重健康类保障外,同时也注重孩子的成长费用
R ( 60mL/min) 早发心血管疾病家族史(男性< 55岁,女性< 65岁) * 代谢综合征 2 靶器官损害( JNC7) 心脏 • 左室肥厚 • 心绞痛或陈旧心肌梗死 • 有冠脉重建史 • 心力衰竭 脑 • 脑卒中或短暂性脑缺血发作 慢性肾脏疾病 周围动脉疾病 视网膜病变 危险分层(欧洲 2020) 其他危险因素和疾病 正常血压 正常血压高值 I级 高血压 II级